TrialBMC cancer2018

Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line chemotherapy.

Max Oberste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.